Crossmark

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset

Crossref DOI link: https://doi.org/10.1038/s41598-017-08091-x

Published Online: 2017-08-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Damkier, Per https://orcid.org/0000-0003-0591-7187
Kjærsgaard, Anders https://orcid.org/0000-0001-9433-6442
Barker, Kimberly A.

Cronin-Fenton, Deidre

Crawford, Anatasha

Hellberg, Ylva

Janssen, Emilius A. M.

Langefeld, Carl

Ahern, Thomas P.

Lash, Timothy L.
License Information

Text and Data Mining valid from 2017-08-10

Version of Record valid from 2017-08-10
More Information

Article History

Received: 11 May 2017

Accepted: 6 July 2017

First Online: 10 August 2017

Competing Interests

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below